FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Manufacturer

Country

Certificates

FDA
Registration Date 16 Nov 2016
Share

Norvir

(0)

Medicine Pharmaceuticals Product Number : 0074-1940-63

Protease Inhibitor

Drug Information

Generic
Ritonavir
NDC Code
0074-1940-63
Drug Class
Protease inhibitors
Therapeutic Class
Antiretroviral Agent
Dosage form
Solution
Route of Administration
Oral
Therapeutic Area
1.antiretroviral

Indication

Norvir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

Benefit

In the first study of Norvir as an antiviral medicine, 16% of the Norvir-treated patients (86 out of 543) experienced a worsening of disease or died, compared with 33% of the patients taking placebo (181 out of 547). In the second study, patients taking Norvir had greater reductions in viral load and increases in CD4 cell counts than those taking zidovudine alone. The combination of Norvir and zidovudine was less effective than Norvir alone, although the reasons for this were unclear. Norvir, in combination with other antiviral medicines, also reduced viral loads in children.